Amgen stock: buy or sell

AMGN stock price: $258.78 -0.14% At close on Apr 21st, 2021

Updated on:
Apr 22nd, 2021


Amgen stock brief

  • Amgen closed on Wednesday at $258.78 after only moving a -0.14% and broke a streak of 4 sessions in green.
  • The price is currently above the upper Bollinger band, which is usually an indicator of a short-term correction
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Should I buy Amgen stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is $AMGN stock a buy?

In the current situation of Amgen there is not any eligible buy setup. This doesn't mean we expect a selloff for $AMGN in the next few days, or that it may not climb higher. Simply, it doesn't match our recommended trading systems

Should I sell Amgen stock?

When is it time to sell Amgen stock?. Like when we have to buy shares, determining when is appropiate to sell is not a random decision, and we must adhere our own trading strategy. Our trading system selects very simple setups to guide us on when is a good time to sell our shares. Be aware that these setups are not intended for shorting $AMGN stock

A guiding principle is that you must never hold an open trade that produces losses greater than those expected at the time of purchase. The moment to sell your stock must always be dictated by the stop-loss (automatic or manual)

Is it time to sell Amgen stock?

Currently, Amgen stock doesn't match any of our preferred sell setups, so if you hold Amgen shares and your operation is in profit probably is not time to sell now

Amgen ratings

In the last month, just one analyst rating was published for Amgen

Amgen analysts' ratings - Last month
Brokerage firmRating
Apr 5th, 2021
Oppenheimer Neutral

Amgen stock analysis

Since the price bottomed at $220.25 in early March, the stock surged by 17.49%.

SMAs overview

AMGN stock SMAs chart

Supports and resistances

The current resistances are:

  • R1: $259.50 (0.28% above)
  • R2: $274.65 (6.13% above)
  • The current support levels are:

  • S1: $256.40 (-0.92% below)
  • S2: $254.87 (-1.51% below)
  • S3: $242.38 (-6.34% below)
  • Bollinger bands

    When the price moves out of the band (above the upper line or below the lower line) it means that the price action is currently maintaining a very strong trend and therefore can correct the trend to the average. For this case, the price is above the upper band, and that should mean a possible near-term correction (at least) until it is below the band

    AMGN stock Bollinger Bands chart

    Relative strength index

    Crossed up the overbought line Wednesday, with a value of 70.24. The fact that the value is in the overbought zone does not imply a sell signal, as stocks can be above 70 for many, many weeks and may continue to rise

    AMGN stock RSI chart

    Amgen stock price history

    Amgen went public priced at an adjusted price1 of $0.00 on Jun 1983. Since then, AMGN stock surged by -, with an average of 0.00% per year. An investment of thousand dollars on the IPO would have a value of $inf nowadays.

    1: Adjusted price after possible price splits or reverse-splits

    AMGN stock price history chart

    Price target for Amgen stock

    How much a stock will be priced tomorrow or next week is quite unpredictable. However, many stock price predictions are issued every day by banks, financial institutions and independent analysts.

    Along with buy or sell recommendations, brokerage institutions release their price estimates based on the stock price action and the company fundamental data. Most of these predictions follow the release of new financial data by the company, and usually. If you are a small investor you shouldn't trade based on these forecasts.

    There is just one price target issued for Amgen that forecasts a price of $275.00.

    Amgen stock price predictions
    Brokerage firmPrice target
    Apr 5th, 2021
    Oppenheimer $266.00$275.00

    Earnings and financials

    Last February, Amgen Inc. ($AMGN) posted adjusted EPS for that improved Wall St. expectations. Quarterly EPS was $3.81 per share versus the estimated $3.39. This quarterly report means an earnings surprise of 12.39%. On the contrary, the company said turnover was $6.6 billion in line with analysts' estimates.

    This compares to Earnings of $3.64 per share a year ago, so reported EPS means a gain of 4.67%. Looking at revenues, figures inched a 7.05% compared to $62.0B same quarter 12 months ago.

    Amgen ($AMGN) releases financial report on Thursday next week. Forecasted for this quarter is $4.03, compared to $3.81 that was reported for Q4.

    Amgen performance

    AMGN performance compared
    Amgen ($AMGN) 3.50% 3.50% 13.60%

    The comments written in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this report does not know the specific positions of the reader, his or her own financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are published for informational motives only

    Amgen summary

    Wednesday, April 21st, 2021
    Day range$257.75 - $261
    Previous close$259.14
    Session gain-0.14%
    Average true range$4.43
    50d mov avg$240.20
    100d mov avg$236.36
    200d mov avg$237.19
    Earnings dateApril 29th, 2021

    Frequently asked questions

    What is Amgen stock symbol?

    Amgen Inc. is a public company trading in the US stock market with the AMGN symbol

    Is Amgen stock a buy or sell?

    Amgen had one rating in the last 4 weeks Read the article to get additional tips on trading AMGN stock.

    Will AMGN go up?

    Amgen had different price forecasts published by analysts in the last 4 weeks forecasting the target price to $275.00. That is a 6.27% than the current price ($258.78).